WASHINGTON--The Physician Payment Review Commission (PPRC) released a study describing how managed care plans select and pay physicians in their networks. The study, conducted by Mathematica Policy Research and the Medical College of Virginia, is the first systematic attempt to compare forms of managed care.
WASHINGTON--The Physician Payment Review Commission (PPRC) releaseda study describing how managed care plans select and pay physiciansin their networks. The study, conducted by Mathematica PolicyResearch and the Medical College of Virginia, is the first systematicattempt to compare forms of managed care.
The survey of 108 HMOs and PPOs with a total patient enrollmentof 33 million people found that managed care has significantlychanged the way physicians practice. The future will bring morechanges, including less independence and less flexibility in practiceparameters. At the same time, however, the study revealed thatmanaged care plans create clinically cohesive organizations thatuse information to improve quality of care.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.